From the USA: In Utero Exposure to Antiseizure Meds Does Not Affect Child Creativity
There are no differences in creative thinking at age 4.5 years for children of women with epilepsy (WWE) and children of healthy women (HW), but fetal antiseizure medication (ASM) exposure-dependent effects are seen for executive function in children of WWE, according to a study published online May 29 in Neurology.
Kimford J. Meador, M.D., from Stanford University in Palo Alto, California, and colleagues examined fetal exposure of newer ASMs on creativity and executive functions in 4.5-year-old children of WWE compared with children of HW. The primary analysis included 251 and 73 children of WWE and HW, respectively.
Source: Advances and More licensed by HealthDay
